Table 2.
PM | N-PM | p | |
---|---|---|---|
Procedural success, n (%) |
23 (100) |
22 (100) |
0.999 |
Conversion to surgical AVR, n (%) |
0 (0) |
0 (0) |
0.999 |
Intraprocedural circulatory depression, n (%) |
4 (17.4) |
2 (9.1) |
0.635 |
Catecholamine therapy, n (%) |
4 (17.4) |
2 (9.1) |
0.714 |
Resuscitation, n (%) |
1 (4.4) |
0 (0) |
0.553 |
Defibrillation, n (%) |
1 (4.4) |
0 (0) |
0.612 |
Vascular access site complication, n (%) |
5 (21.8) |
4 (18.2) |
0.367 |
Contrast agent (ml) |
113.3 ± 36.4 |
125.5 ± 60.8 |
0.732 |
Fluoroscopy time (min) |
25.7 ± 1.8 |
23.9 ± 2.6 |
0.572 |
Procedure time (min) |
107.7 ± 27.1 |
104.9 ± 33.3 |
0.725 |
CoreValve, n (%) | |||
26mm |
10 (43.5) |
12 (54.6) |
0.112 |
29mm |
13 (56.6) |
10 (45.5) |
0.386 |
Pre TAVI, n (%) |
23 (100) |
22 (100) |
0.999 |
Post TAVI valvuloplasty, n (%) |
10 (43.5) |
10 (45.5) |
0.566 |
Number of inflations, n (%) |
1.08 ± 0.75 |
1.14 ± 0.94 |
0.335 |
Balloon diameter (mm) |
21.87 ± 3.84 |
21.27 ± 4.44 |
0.432 |
Balloon length (mm) |
55.22 ± 26.81 |
52.73 ± 30.27 |
0.613 |
Angiographic Aortic insufficiency (grade) |
1.22 ± 0.48 |
1.10 ± 0.62 |
0.725 |
ICU stay (days) |
2.9 ± 3.2 |
2.5 ± 1.8 |
0.686 |
Hospital stay (days) | 13.4 ± 11.3 | 12.0 ± 6.5 | 0.237 |